AstraZeneca hopes to settle EU legal dispute in coming weeks - exec
- Country:
- United Kingdom
AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially ending a row that has dogged the drug maker and Brussels this year.
The company is in talks with the EU, Ruud Dobber, executive vice president of the BioPharmaceuticals business, said on a briefing.
"We're hopeful in the next few weeks we will have a settlement," he said without giving further details.
ALSO READ
-
Belize Communities Take the Lead in New Push for Jobs, Skills and Stronger Futures
-
Hotter Years, More Cavities? Understanding Link Between Climate and Dental Health
-
Europe’s Rare Earth Wake-Up Call: Turning Years of Research Into Factories That Last
-
Lebanon’s Small Business Owners Build Skills and Market Links With EU and ILO Support
-
Poltava University Reopens With Safer, Greener Spaces for Nearly 3,000 Campus Users
Google News